Toshiaki Sendo

3.5k total citations
210 papers, 2.7k citations indexed

About

Toshiaki Sendo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Toshiaki Sendo has authored 210 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 37 papers in Cellular and Molecular Neuroscience and 34 papers in Pharmacology. Recurrent topics in Toshiaki Sendo's work include Pharmacy and Medical Practices (28 papers), Neuroscience and Neuropharmacology Research (26 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Toshiaki Sendo is often cited by papers focused on Pharmacy and Medical Practices (28 papers), Neuroscience and Neuropharmacology Research (26 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Toshiaki Sendo collaborates with scholars based in Japan, United States and United Kingdom. Toshiaki Sendo's co-authors include Ryozo Oishi, Yoshinori Itoh, Yoshihisa Kitamura, Takahisa Yano, Yutaka Gomita, Toshio Kubota, Masato Asanuma, Ikuko Miyazaki, Toshihiro Koyama and Takeshi Goromaru and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Toshiaki Sendo

194 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiaki Sendo Japan 27 602 390 366 243 223 210 2.7k
Massimo Fini Italy 40 1.2k 2.0× 284 0.7× 243 0.7× 120 0.5× 180 0.8× 126 5.0k
Antonio López‐Farré Spain 39 1.2k 2.0× 379 1.0× 276 0.8× 226 0.9× 230 1.0× 182 5.0k
Dawei Ye China 34 1.0k 1.7× 238 0.6× 449 1.2× 330 1.4× 59 0.3× 72 3.8k
C. Bolton United Kingdom 36 632 1.0× 222 0.6× 251 0.7× 225 0.9× 168 0.8× 111 3.8k
Ichiro Wakabayashi Japan 29 778 1.3× 224 0.6× 152 0.4× 178 0.7× 141 0.6× 271 3.8k
Michael Bodmer Switzerland 33 1.5k 2.4× 590 1.5× 745 2.0× 194 0.8× 134 0.6× 77 4.4k
Uttam Garg United States 27 1.0k 1.7× 411 1.1× 114 0.3× 281 1.2× 202 0.9× 155 4.6k
Minjie Wei China 30 1.4k 2.3× 393 1.0× 302 0.8× 127 0.5× 703 3.2× 83 5.5k
Zhe Feng China 33 1.3k 2.1× 263 0.7× 246 0.7× 134 0.6× 580 2.6× 150 3.4k
Hafize Uzun Türkiye 42 1.2k 2.0× 502 1.3× 329 0.9× 157 0.6× 161 0.7× 321 6.2k

Countries citing papers authored by Toshiaki Sendo

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Sendo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Sendo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Sendo more than expected).

Fields of papers citing papers by Toshiaki Sendo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Sendo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Sendo. The network helps show where Toshiaki Sendo may publish in the future.

Co-authorship network of co-authors of Toshiaki Sendo

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Sendo. A scholar is included among the top collaborators of Toshiaki Sendo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Sendo. Toshiaki Sendo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koyama, Toshihiro, Hideharu Hagiya, Ko Harada, et al.. (2021). Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan. Drug Safety. 44(5). 531–539. 4 indexed citations
3.
Koyama, Toshihiro, Hideharu Hagiya, Yoshito Zamami, et al.. (2019). Place of death trends among patients with dementia in Japan: a population-based observational study. Scientific Reports. 9(1). 20235–20235. 16 indexed citations
4.
Yamamoto, Hiromasa, Ken Suzawa, Shuta Tomida, et al.. (2019). YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers. Cancer Science. 111(3). 849–856. 17 indexed citations
5.
Kitamura, Yoshihisa, et al.. (2018). Influence of lipopolysaccharide on diazepam-modified loss of righting reflex duration by pentobarbital treatment in mice. European Journal of Pharmacology. 842. 231–238. 8 indexed citations
6.
Sato, Shiho, Yoshito Zamami, Toru Imai, et al.. (2017). Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia. Scientific Reports. 7(1). 12683–12683. 7 indexed citations
7.
Yamamoto, Hiromasa, Hirotaka Kanzaki, Ken Suzawa, et al.. (2017). Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. PLoS ONE. 12(2). e0171356–e0171356. 29 indexed citations
8.
Isozaki, Hideko, Eiki Ichihara, Nagio Takigawa, et al.. (2016). Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases. Cancer Research. 76(6). 1506–1516. 109 indexed citations
9.
Nishihara, Shigeki, et al.. (2016). <b>Survey of Institutional Review Boards in Japan </b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 47(3). 105–113.
10.
Matsunaga, Hisashi, et al.. (2011). Drug interaction (20. combination with enteral nutrition formulas). Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 123(1). 59–62. 1 indexed citations
11.
Kitamura, Yoshihisa, et al.. (2009). Evaluation of Method for Pinpointing Areas for Improvement in Practical Training at Hospital Pharmacy. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(3). 202–208. 7 indexed citations
12.
Kitamura, Yoshihisa, et al.. (2008). Analysis of Learning Outcomes for Specific Behavioral Objective in Model Core Curriculum. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 34(11). 1042–1050. 4 indexed citations
13.
Kitamura, Yoshihisa, et al.. (2007). Evaluation of a Newly Developed Educational Program for Pharmacy Students (Part 3)-Introduction of Portfolio Assessment into Training Program for Inpatient Pharmaceutical Care-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(7). 591–600. 9 indexed citations
14.
Kitamura, Yoshihisa, et al.. (2007). Development of New Practical Training Program for Pharmacy Students and its Evaluation (Part 2)-Training in Inpatient Pharmaceutical Care Based on Model Core Curriculum-. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(4). 339–346. 7 indexed citations
15.
Yokoyama, Noriko, et al.. (2007). Medical Economics Evaluation of Pharmacist Intervention in Outpatient Antineoplastic Chemotherapy. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(10). 883–887. 4 indexed citations
16.
Nishihara, Shigeki, Hironori Yoshitomi, Yuji Kurosaki, et al.. (2006). Evaluation of Newly Developed Educational System for Pharmacy Students through Preliminary Training Trial on Dispensing Practice. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 32(10). 1044–1049. 4 indexed citations
17.
Itoh, Yoshinori, Toshiaki Sendo, & Ryozo Oishi. (2006). . Folia Pharmacologica Japonica. 127(6). 425–432. 10 indexed citations
18.
Yokoyama, Noriko, et al.. (2006). Sterility Management for Preparation of Antineoplastic Agents in a Class II Biological Safety Cabinet. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 32(12). 1261–1266. 1 indexed citations
19.
Mori, Shuji, Yoshinori Itoh, Ryoko Shinohata, et al.. (2003). Nafamostat Mesilate Is an Extremely Potent Inhibitor of Human Tryptase. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Itoh, Yoshinori, Toshiaki Sendo, Toshio Hirakawa, et al.. (2003). Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity. American Journal of Respiratory and Critical Care Medicine. 169(1). 113–119. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Fini Breakdown of academic impact, for papers by Antonio López‐Farré Breakdown of academic impact, for papers by Dawei Ye Breakdown of academic impact, for papers by C. Bolton Breakdown of academic impact, for papers by Ichiro Wakabayashi Breakdown of academic impact, for papers by Michael Bodmer Breakdown of academic impact, for papers by Uttam Garg Breakdown of academic impact, for papers by Minjie Wei Breakdown of academic impact, for papers by Zhe Feng Breakdown of academic impact, for papers by Hafize Uzun
Rankless by CCL
2026